Beranda › Kanker Prostat › California › San Francisco
Uji klinis Kanker Prostat di San Francisco, CA
45 studi untuk Kanker Prostat mencari peserta di lokasi sekitar San Francisco (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- Research Site, San Francisco
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Menerima pesertaFase 3
- Kaiser Permanente-San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
- Kaiser Permanente-San Francisco, San Francisco
Precision-Based Genomics in Prostate Cancer
Menerima pesertaStudi observasional
- University of California San Francisco, San Francisco
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Menerima pesertaFase 3
- San Francisco VA Health Care System ( Site 0093), San Francisco
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Menerima pesertaFase 3
- University of California San Francisco, San Francisco
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Menerima peserta
- University of California San Francisco, San Francisco
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Menerima pesertaFase 2
- University of California, San Francisco, San Francisco
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Menerima pesertaFase 3
- Kaiser Permanente-San Francisco, San Francisco
Prostate Active Surveillance Study
Menerima pesertaStudi observasional
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study of Tarlatamab for People With Prostate Cancer
Menerima pesertaFase 2
- University of California San Francisco, San Francisco
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Menerima pesertaFase 1
- University of California, San Francisco, San Francisco
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Menerima pesertaStudi observasional
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Menerima pesertaFase 3
- Research Site, San Francisco
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Menerima pesertaFase 1
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Menerima pesertaFase 2
- University of California San Francisco, San Francisco
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Menerima pesertaFase 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- University of California San Francisco Cancer Center, San Francisco
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Menerima pesertaFase 1
- University of California San Francisco, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Menerima pesertaFase 1/2
- University of California, San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
Menerima pesertaFase 1
- University of California, San Francisco, San Francisco
PSMA PET Combined With MRI for the Detection of PCa
Menerima pesertaFase 3Sukarelawan sehat diterima
- University of California San Francisco, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Menerima pesertaFase 1
- University of California San Francisco, San Francisco
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
Menerima pesertaStudi observasional
- University of California, San Francisco, San Francisco
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Menerima pesertaFase 2
- University of California San Francisco, San Francisco
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Menerima pesertaFase 1
- University of California San Francisco, San Francisco
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
Menerima pesertaFase 2
- University of California, San Francisco, San Francisco
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
Menerima pesertaFase 1
- University of California, San Francisco, San Francisco
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Menerima pesertaFase 2
- University of California, San Francisco, San Francisco
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of California, San Francisco, San Francisco
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Menerima peserta
- UCSF, San Francisco
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
Menerima pesertaFase awal 1
- University of California, San Francisco, San Francisco
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Menerima peserta
- University of California, San Francisco
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Menerima pesertaFase 3
- Kaiser Permanente-San Francisco, San Francisco
Mechanisms of Resistance to PSMA Radioligand Therapy
Menerima pesertaStudi observasional
- University of California, San Francisco, San Francisco
64Cu-GRIP B in Patients With Advanced Malignancies
Menerima pesertaFase 1/2
- University of California, San Francisco, San Francisco
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
Menerima peserta
- San Francisco Veterans Affairs Medical Center, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Menerima pesertaFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Menerima pesertaFase 1
- University of California San Francisco, San Francisco
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
Menerima pesertaFase 2
- University of California, San Francisco, San Francisco
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
Menerima peserta
- Zuckerberg San Francisco General Hospital, San Francisco
- San Francisco Veterans Administration Medical Center, San Francisco
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, San Francisco
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Menerima pesertaFase 3
- Kaiser Permanente-San Francisco, San Francisco
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Menerima pesertaStudi observasional
- University of California, San Francisco, San Francisco
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
- Dallas, TX36 studi
Studi lain di San Francisco
- Kanker Payudara43 studi
- Kanker Paru Non-Sel Kecil36 studi
- Kanker (semua jenis)35 studi
- Gagal Jantung29 studi
- Kanker Metastatik28 studi
- Kanker Paru22 studi
- Melanoma22 studi
- Kanker Pankreas20 studi
- Kanker Ovarium19 studi
- Kanker Kolorektal18 studi
- Penyakit Kardiovaskular18 studi
- Glioblastoma17 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.